Avalo Therapeutics (AVTX) Divestments (2019)
Avalo Therapeutics (AVTX) posted Divestments of $4.0 million for Q4 2019.
Avalo Therapeutics (AVTX) Divestments (2019) Analysis & Trends
Avalo Therapeutics' Divestments history runs 1 years deep, the most recent figure standing at $4.0 million for Q4 2019.
- Quarterly Divestments changed N/A year-over-year to $4.0 million in Q4 2019, while the trailing twelve-month figure through Sep 2021 was $4.0 million (changed N/A YoY) and the FY2020 annual result came in at $12.8 million, up 224.3% from the prior year.
- Divestments was $4.0 million for Q4 2019 at Avalo Therapeutics.
- Across five years, Divestments topped out at $4.0 million in Q4 2019 and bottomed at $4.0 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3.96 Mn |